BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 3005822)

  • 1. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Dec; 34(48):721-6, 731-2. PubMed ID: 2999576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS: a challenge for the public health.
    Acheson ED
    Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AIDS in Africa].
    Sansone R; Carobbi S; Alloro G; Strigini P
    Ann Ig; 1989; 1(5):1057-66. PubMed ID: 2483891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leads from the MMWR. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    JAMA; 1986 Apr; 255(14):1843-4, 1849. PubMed ID: 3005680
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS epidemic sparks campaign to encourage condom use.
    Contracept Technol Update; 1985 Dec; 6(12):161-3. PubMed ID: 12280299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Jun; 104(6):824-5. PubMed ID: 3010783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual self-defense versus the liaison dangereuse: a strategy for AIDS prevention in the '90s.
    Nelson EW
    Am J Prev Med; 1991; 7(3):146-9. PubMed ID: 1931142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS: the search for clues.
    WHO Chron; 1985; 39(6):207-11. PubMed ID: 3012884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.